Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Stock Picks Today: Dr Lal Path, Axis Bank, Syrma SGS, Delhivery, And More On Brokerages' Radar
Brokerages' Radar
India's peak power demand set to hit 300 GW next year: Manohar Lal
Speaking at the 12th India Energy Storage Week (IESW) 2026 in the national capital, the minister highlighted that according to estimates, India has already reached (peak power demand of) 271 GW, and projections suggest the peak may rise even further this year.
Why Are Indians Dying Of Heart Attacks In Their 40s? Dr Arvind Lal Has Been Trying To Answer That For Decades
Dr. Lal PathLabs founder Arvind Lal on why Indians are dying of heart attacks in their 40s, why health insurance won't cover the tests that could prevent it, and what five basic blood tests every Indian should get by 25.
Dr Lal PathLabs soars 11%, hits 52-week high on huge volumes; here's why
Care Ratings expects Dr Lal PathLabs' revenue to grow by 11-12 per cent per annum in the near-to-medium term driven by organic demand growth, its expanding geographical presence and new initiatives.
Sonata Software Ltd leads gainers in 'A' group
Va Tech Wabag Ltd, Dr Lal Pathlabs Ltd, MMTC Ltd and Hindustan Construction Company Ltd are among the other gainers in the BSE's 'A' group today, 16 June 2026.
Dr Lal PathLabs establishes UAE subsidiary to pursue diagnostics opportunities
Shares of Dr Lal PathLabs Ltd ended at ₹1,601.20, up by ₹7.45, or 0.47%, on the BSE.
Alkali Metals Ltd leads gainers in 'B' group
NIIT Ltd, Lorenzini Apparels Ltd, Deep Polymers Ltd and Rubicon Research Ltd are among the other gainers in the BSE's 'B' group today, 01 June 2026.
Centre targets nearly 300 GW power generation capacity by next year: Manohar Lal Khattar
India is boosting its power generation capacity, focusing on nuclear energy. The nation aims to reach nearly 300 GW next year. Nuclear power is key for long-term energy security, targeting 100 GW by 2047. Tripura is set to receive urban infrastructure projects worth Rs 1,200 crore. Reforms are crucial for growth.
Dr. Lal Pathlabs among 5 stocks showing bullish RSI upswing
Five stocks from the Nifty500 universe were flagged in the RSI Trending Up scan on May 4 after gaining over 4%. The indicator turned positive as RSI crossed above 50 from lower levels, signalling improving momentum, strengthening sentiment, and potential short-term buying opportunities in select stocks.
Dr Lal Pathlabs Sees Target Price Cut From ICICI Securities After Q4 Results — Here's Why
Dr. Lal's management anticipates strong momentum in the Delhi NCR market and better traction in Suburban Diagnostics to translate into 13-15% revenue growth for FY27.
Here's why these two healthcare stocks are surging up to 10% on Monday
Healthcare stocks are in focus today, with shares of Dr Lal PathLabs and Aster DM Healthcare rallying after their March quarter earnings and upbeat brokerage commentary.
Q4 Results LIVE Updates: Sundram Fasteners profit up 30%; ESAF SFB NII grows 20%
Q4 Results LIVE Updates: Today is the busiest day in terms of quarterly results this week. The big earnings reaction of the day comes from Bajaj Finance where brokerages have raised their targets and even upgraded the stock, along with Waaree Energies, who also issued its guidance for FY27. The biggest result of the day comes from Hindustan Unilever (HUL), followed by Adani twins on the Nifty (Ports & Enterprises), Bajaj Finserv, ACC, Laurus Labs, Dr. Lal Pathlabs, RailTel, Newgen Software and others. Follow for all the Live updates.